1921
Volume 89, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The Nine Mile phase II clone 4 (NMIIC4) strain of is an attenuated phase II strain that has lost the genes for virulence determinant type 1 lipopolysaccharide. These bacteria were very virulent for severe combined immunodeficient (SCID) mice. The lethal dose 50 (LD) was ∼10 bacteria. Infected SCID mice died between Day 28 and Day 53 post-infection. At termination of the experiment (Day 60) only 5 of 24 mice had survived. The degree of splenomegaly was directly related to the bacterial load in the SCID mice spleens. The NMIIC4 was avirulent in immunocompetent wild mice and bacterial DNA copies in splenic tissue were extremely low. The SCID mice that were inoculated with high doses of heat inactivated NMIIC4 were all alive at Day 60 and without splenomegaly. It appears that the phase I lipopolysaccharide present in virulent Nine Mile phase I but not in attenuated NMIIC4 is not the only virulence factor for .

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.12-0653
2013-10-09
2017-09-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/89/4/800.html?itemId=/content/journals/10.4269/ajtmh.12-0653&mimeType=html&fmt=ahah

References

  1. Derrick EH, , 1937. ‘Q’ fever, a new fever entity: clinical features, diagnosis and laboratory investigation. Med J Aust 11: 281299.
  2. Ftacek P, Skultety L, Toman R, , 2000. Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide. J Endotoxin Res 6: 369376.[Crossref]
  3. Slaba KA, Hussein A, Palkovic P, Horváth V, Toman R, , 2003. Studies on the immunological role of virenose and dihydrohydroxystreptose present in the Coxiella burnetii phase I lipopolysaccharide. Ann N Y Acad Sci 990: 505509.[Crossref]
  4. Amano KI, Williams JC, Missler SR, Reinhold VN, , 1987. Structure and biological relationships of Coxiella burnetii lipopolysaccaharides. J Biol Chem 262: 47404747.
  5. Hackstadt T, Peacock MG, Hitchcock PJ, Cole RL, , 1985. Lipopolysaccharide variation in Coxiella burnetii: intrastrain heterogeneity in structure and antigenicity. Infect Immun 48: 359365.
  6. Hackstadt T, , 1986. Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun 52: 337340.
  7. Hoover T, Culp D, Vodkin M, Williams J, Thompson H, , 2002. Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain. Infect Immun 70: 67266733.[Crossref]
  8. Denison AM, Massung RF, Thompson HA, , 2007. Analysis of the O-antigen biosynthesis regions of phase II Isolates of Coxiella burnetii . FEMS Microbiol Lett 267: 102107.[Crossref]
  9. Vodkin MH, Williams JC, , 1986. Overlapping deletion in two spontaneous phase variants of Coxiella burnetii . J Gen Microbiol 132: 25872594.
  10. Moos A, Hackstadt T, , 1987. Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect Immun 55: 11441150.
  11. Waag DM, England MJ, Pittet ML, , 1997. Comparative efficacy of a Coxiella burnetii chloroform: methanol residue (CMR) vaccine and a licensed cellular vaccine (QVax) in rodents challenged by aerosol. Vaccine 15: 17791783.[Crossref]
  12. Zhang GQ, Samuel JE, , 2003. Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I. Ann N Y Acad Sci 990: 510520.[Crossref]
  13. Andoh M, Russell-Lodrigue KE, Zhang G, Samuel JE, , 2005. Comparative virulence of phase I and II Coxiella burnetii in immunodeficient mice. Ann N Y Acad Sci 1063: 167170.[Crossref]
  14. Andoh M, Zhang G, Russell-Lodrigue KE, Shive HR, Weeks BR, Samuel JE, , 2007. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect Immun 75: 32453255.[Crossref]
  15. Ochoa-Repáraz J, Sentissi J, Trunkle T, Riccardi C, Pascual DW, , 2007. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection. Infect Immun 75: 58455858.[Crossref]
  16. Miller JD, Curns AT, Thompson HA, , 2004. A growth study of Coxiella burnetii Nine Mile phase I and phase II in fibroblasts. FEMS Immunol Med Microbiol 42: 291297.[Crossref]
  17. Bosma GC, Custer RP, Bosma MJ, , 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301: 527530.[Crossref]
  18. Dorshkind K, Keller GM, Phillips RA, Miller RG, Bosma GC, O'Toole M, Bosma MJ, , 1984. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol 132: 18041808.
  19. Bosma GC, Fried M, Custer RP, Carroll A, Gibson DM, Bosma MJ, , 1988. Evidence of functional lymphocytes in some (Leaky) SCID mice. J Exp Med 167: 10161033.[Crossref]
  20. Andoh M, Naganawa T, Hotta A, Yamaguchi T, Fukushi H, Masegi T, Hirai K, , 2003. SCID mouse model for lethal Q fever. Infect Immun 71: 47174723.[Crossref]
  21. Russell-Lodrigue KE, Andoh M, Poels MW, Shive HR, Weeks BR, Zhang GQ, Tersteeg C, Masegi T, Hotta A, Yamaguchi T, Fukushi H, Hirai K, McMurray DN, Samuel JE, , 2009. Coxiella burnetii isolates cause genogroup-specific virulence in mouse and guinea pig models of acute Q fever. Infect Immun 77: 56405650.[Crossref]
  22. Lockhart M, Graves S, Banazis M, Fenwick S, Stenos J, , 2011. A comparison of methods for extracting DNA from Coxiella burnetii as measured by a duplex qPCR assay. Lett Appl Microbiol 52: 514520.[Crossref]
  23. Lockhart MG, Islam A, Graves GR, Fenwick S, Stenos J, , 2012. Detecting and Measuring Small Numbers of viable Coxiella burnetii . FEMS Immunol Med Microbiol 64: 6165.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.12-0653
Loading
/content/journals/10.4269/ajtmh.12-0653
Loading

Data & Media loading...

  • Received : 24 Oct 2012
  • Accepted : 24 Jul 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error